A systematic literature review informing the consensus statement on efficacy and safety of pharmacol...
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases
About this item
Full title
Author / Creator
Kastrati, Kastriot , Aletaha, Daniel , Burmester, Gerd R , Chwala, Eva , Dejaco, Christian , Dougados, Maxime , McInnes, Iain B , Ravelli, Angelo , Sattar, Naveed , Stamm, Tanja A , Takeuchi, Tsutomu , Trauner, Michael , van der Heijde, Desirée , Voshaar, Marieke J H , Winthrop, Kevin , Smolen, Josef S and Kerschbaumer, Andreas
Publisher
London: EULAR
Journal title
Language
English
Formats
Publication information
Publisher
London: EULAR
Subjects
More information
Scope and Contents
Contents
ObjectivesInforming an international task force updating the consensus statement on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) selectively targeting interleukin-6 (IL-6) pathway in the context of immune-mediated inflammatory diseases.MethodsA systematic literature research of all publications on IL-6 axis inhi...
Alternative Titles
Full title
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_07c0e01a19cd41a7ac3ac3a49ec670ab
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_07c0e01a19cd41a7ac3ac3a49ec670ab
Other Identifiers
ISSN
2056-5933
E-ISSN
2056-5933
DOI
10.1136/rmdopen-2022-002359
